Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome.
about
Obstructive sleep apnea syndrome and fatty liver: association or causal link?Clinical manifestations of sleep apneaInvestigation and management of childhood sleep apnoeaManagement of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver diseaseCoagulability in obstructive sleep apneaObstructive sleep apnea syndrome and cardiovascular disease: The influence of C-reactive proteinObstructive sleep apnea and dyslipidemia: implications for atherosclerosisSleep: important considerations for the prevention of cardiovascular diseaseChanges in obstructive sleep apnea severity, biomarkers, and quality of life after multilevel surgery.Inflammatory markers in middle-aged obese subjects: does obstructive sleep apnea syndrome play a role?Sleep-disordered breathing and cardiovascular disorders.Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers - a meta-analysisBiomarkers to improve diagnosis and monitoring of obstructive sleep apnea syndrome: current status and future perspectives.Abnormalities of lipoprotein concentrations in obstructive sleep apnea are related to insulin resistanceObstructive sleep apnoea syndrome: a new paradigm by chronic nocturnal intermittent hypoxia and sleep disruption.Continuous positive airway pressure treatment: effect on serum lipids in patients with obstructive sleep apnoea.Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology.The interaction of obstructive sleep apnea and obesity on the inflammatory markers C-reactive protein and interleukin-6: the Icelandic Sleep Apnea Cohort.Beneficial effect of continuous positive airway pressure on lipid profiles in obstructive sleep apnea: a meta-analysis.Biomarkers of sleep apneaSerum Levels of Vascular Endothelial Growth Factor and Insulin-like Growth Factor Binding Protein-3 in Obstructive Sleep Apnea Patients: Effect of Continuous Positive Airway Pressure Treatment.Obstructive sleep apnea syndrome: natural history, diagnosis, and emerging treatment optionsCognition and biomarkers of oxidative stress in obstructive sleep apneaObstructive sleep apnea syndrome and asthma: what are the links?Long-term effect of continuous positive airway pressure therapy on inflammation markers of patients with obstructive sleep apnea syndrome.Changes in regional adiposity and cardio-metabolic function following a weight loss program with sibutramine in obese men with obstructive sleep apnea.Metabolic consequences of sleep-disordered breathing.Patients with severe obstructive sleep apnea syndrome and elevated high-sensitivity C-reactive protein need priority treatment.Effect of continuous positive airway pressure on C-reactive protein levels in sleep apnea: a meta-analysis.The effect of continuous positive airway pressure on metabolic variables in patients with obstructive sleep apnoea.What can blood biomarkers tell us about cardiovascular risk in obstructive sleep apnea?CPAP therapy induces favorable short-term changes in epicardial fat thickness and vascular and metabolic markers in apparently healthy subjects with obstructive sleep apnea-hypopnea syndrome (OSAHS).Effects of nCPAP therapy on cardiorespiratory outcomes in obstructive sleep apnea syndrome: compliance and technological advancements.Epicardial fat thickness regression with continuous positive airway pressure therapy in patients with obstructive sleep apnea: assessment by two-dimensional echocardiography.Observational pilot study of reported symptoms of obstructive sleep apnoea in children with epilepsy.Evaluation of blood pressure control in an obstructive sleep apnea population followed in cardiology.Lipid profile after long-term APAP in OSA patients.Guidelines for diagnosing and treating sleep related breathing disorders in adults and children (Part 2: treatment).CPAP does not reduce inflammatory biomarkers in patients with coronary artery disease and nonsleepy obstructive sleep apnea: a randomized controlled trial.Elevated serum cystatin C in severe OSA younger men without complications.
P2860
Q24612841-60647EF9-48A4-4A01-93E3-D5F601FA9848Q26778707-17F759EC-4511-4B6E-9229-B8DBE2AE2835Q26820561-BA5176D5-787A-4E2A-ABEC-3D7EC3319341Q26827665-D99843DE-920F-4A27-9DB2-3C13E9970607Q26830210-DAAC0D7A-3385-4919-9AF9-D57743A6FC92Q27003309-2C28F2C5-165A-4443-9641-B3B30841716FQ27693900-703A4DD7-E135-4F1A-B3F2-E24B180C83BBQ28391278-E53510A7-D748-4733-8F3D-25F7FA275B58Q33870399-20CA4428-D0D8-440C-8F96-22BDBD6F1441Q33984737-D4D634B0-2CD2-4393-9672-B5768C63CD4FQ34273305-71C7BE16-56A4-4637-926E-2F9B81844D60Q34631136-C76DD474-31B1-4B3B-8948-8B3FA9081EABQ34697950-EB156156-AF72-433D-A185-605F5228587EQ35478454-CBB22C7B-C16C-469C-B7D4-F9CB993D1CFFQ35645816-6EB371EF-9F92-4119-AE07-F0AEBD0D8C00Q35646020-2A068CE5-BCD4-45B9-B79A-1623360FEBA3Q35843452-A0530970-95F0-4E27-A0FC-0E5F02A4A189Q36013859-236559A5-E4C5-44FE-B30C-3DF91BA1CF8EQ36024087-CE6EC514-1CB3-4005-A6D7-EA8ACC912945Q36163526-198E3AC6-100A-4F0E-8D79-00125B19D260Q36622917-69B75714-467D-45D3-8564-CC19F3BC2E86Q36779835-9385BF40-5389-4E26-912C-A2735E592BE1Q36791654-1840A739-442A-4145-AF29-DECB860D61F5Q37086887-D7F2491E-AE6F-4835-882C-7E504D994119Q37146144-A100DCD0-FD62-45FE-9612-086F70A1F346Q37389100-4BC67355-56F7-4790-B170-0FCE137BA61EQ37511434-D1D3D21C-2BB2-4DF1-863C-A8FAE0DAECA7Q37771620-616052AF-01B4-405B-B0F5-ECC1B091120EQ38020106-F879B4F6-174E-44BA-B027-99A8B7609BDDQ38178936-8D443674-8D1E-47C4-B4E7-3B67142B40BCQ38365338-70292223-02FD-4BD2-A452-906B0EC85AA0Q38979771-2B3D346B-E0BB-4EE6-8829-1BE3667898E7Q39779242-D73449F9-71FA-4BCF-9806-54162C269591Q39931236-4AAF3818-FAD1-4D69-BEF4-3AB0C9EC070BQ40694691-49B4538E-FB9A-43A5-B746-252D7B969429Q41039752-A96BDC35-3E68-4E08-BD52-1D8F61FC7EA1Q41686695-AEBBD888-8F2A-4A33-A412-C6CEB88E96B7Q41971954-F4A4C6DF-497E-4A51-B18D-CFCFA025D390Q42696823-F5B9A692-73D1-4137-9CA1-CDF5696A92D9Q43534627-522D4517-A94D-4868-9D3D-D46483324068
P2860
Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Effect of continuous positive ...... sleep apnea-hypopnea syndrome.
@en
Effect of continuous positive ...... sleep apnea-hypopnea syndrome.
@nl
type
label
Effect of continuous positive ...... sleep apnea-hypopnea syndrome.
@en
Effect of continuous positive ...... sleep apnea-hypopnea syndrome.
@nl
prefLabel
Effect of continuous positive ...... sleep apnea-hypopnea syndrome.
@en
Effect of continuous positive ...... sleep apnea-hypopnea syndrome.
@nl
P2093
P356
P1433
P1476
Effect of continuous positive ...... sleep apnea-hypopnea syndrome.
@en
P2093
Christina Fitili
Demosthenes Bouros
Evangelia Nena
Margarita Kataropoulou
Marios Froudarakis
Pandora Christaki
Paschalis Steiropoulos
Venetia Tsara
P304
P356
10.1378/CHEST.07-0074
P407
P577
2007-06-15T00:00:00Z